Rep. James French Hill discloses four stock sales, including Pfizer (PFE) for $100k-$250k, with a total disclosed value between $131,004 and $365,000.
- Filer
- Hon. James French Hill (AR)
- Transactions
- 4 across 3 companies
- Direction
- 0 bought · 4 sold
- Notification date
- 12/31/2025
4 transactions in this filing
| Company | Ticker | Type | Amount | Date |
|---|---|---|---|---|
| Solventum Corp | SOLV | Sale | $15,001 - $50,000 | 12/31/2025 |
| PFIZER INC | PFE | Sale | $100,001 - $250,000 | 2025-12-31 |
and 2 more transactions in this filing
Rep. James French Hill (AR-02) disclosed four stock sales that all occurred on December 31, 2025, according to a Periodic Transaction Report signed on January 23, 2026. The total value of the combined sales is between $131,004 and $365,000.
The largest transaction was the sale of Pfizer, Inc. Common Stock (PFE), valued between $100,001 and $250,000. The filing also included the sale of SFL Corporation Ltd (SFL) and Solventum Corporation Common Stock (SOLV), each valued between $15,001 and $50,000. The smallest transaction was a sale of Kyndryl Holdings, Inc. Common Stock (KD) for an amount between $1,001 and $15,000.
The disclosure document notes that the sales of Pfizer and SFL Corporation were executed for "tax loss purposes." The assets were held in trusts listed as the HILL 1998 TRUST and the HILL 2012 TRUST.
Important Disclaimer
Amounts are disclosed by law as broad ranges, not exact figures - this reflects the range as filed, not a precise dollar amount. This content is summarized from a public government disclosure filing and may contain errors.
The Filing Fool is not a registered investment adviser. Nothing here is a recommendation or solicitation to buy, sell, or hold any security, nor any claim about a filer's intent or knowledge.